Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTULAX vs BOTOX for post-stroke upper limb spasticity (Phase III, randomized, double blind, active-controlled)
KCT0001188Phase 3Completed
- Sponsor
- Hugel
- Start
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in poststroke spasticity (PSS), sponsored by Hugel. Started Aug 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
poststroke spasticity (PSS)
Beyond the preview
Go deeper on KCT0001188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001188.